Clinical Trial Update: A Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction [Phase 4]

View source ↗

Summary

Phase 4 study evaluating pain management with botulinum toxin injections for glabellar line correction has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Injection Site Discomfort

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Galderma R&D | Conditions: Injection Site Discomfort | Phase 4 | Status: COMPLETED